These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1087761)

  • 1. Serological identification of Ia antigens: report of a British region Ia workshop.
    Bodmer J; Pickbourne P; Bodmer W; Batchelor R; Dewar P; Dick H; Entwistle C; Festenstein H; Gelsthorpe K; Joysey V; Mackintosh P; Lawler S; Morris P; Pegrum GD; Harris R; Taylor M
    Tissue Antigens; 1976 Nov; 8(5):359-71. PubMed ID: 1087761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
    Koubek K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The merrit alloantigenic system of human B lymphocytes: evidence for thirteen possible factors including one six-member segregant series.
    Walford RL; Gossett T; Troup GM; Gatti RA; Mittal KK; Robins A; Ferrara GB; Zeller E
    J Immunol; 1976 Jun; 116(6):1704-10. PubMed ID: 1083880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA typing of leukemic cells and lymphoblastoid cell lines: effects of non-HLA antibodies in common typing sera.
    DuBois D; Specian TL; Pollack MS
    Prog Clin Biol Res; 1977; 16():115-28. PubMed ID: 269454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia.
    Pollack MS; DuBois D
    Cancer; 1977 Jun; 39(6):2348-54. PubMed ID: 301430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human lymphoid cell lines as targets for DRw.
    Strong DM; Pellegrino MA; Ferrone S
    In Vitro; 1978 Dec; 14(12):989-95. PubMed ID: 310802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological identification of five HLA-D associated (Ia-like) determinants.
    Albrechtsen D; Solheim BG; Thorsby E
    Tissue Antigens; 1977 Mar; 9(3):153-62. PubMed ID: 67654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Ia-like antigens associated with HLA-d.
    Albrechtsen D; Solheim BG; Thorsby E
    Scand J Immunol; 1977; 6(5):419-25. PubMed ID: 70059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic cross-reaction of murine and human Ia antigens.
    Ing PM; Falk JA; Letarte M; Delovitch TL; Falk RE
    Transplant Proc; 1979 Dec; 11(4):1745-7. PubMed ID: 316937
    [No Abstract]   [Full Text] [Related]  

  • 10. Murine sera cytotoxicity toward human B cells and their effect on human mixed lymphocyte reactions.
    Verghese MW; Ward FE
    Transplantation; 1979 Aug; 28(2):107-10. PubMed ID: 158240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisera with Ia specificity selected by lymphocytes from patients with chronic lymphocytic leukemia.
    Lawler SD; Dewar PJ; Mrazek I; Jones EH; Hockley AB
    Vox Sang; 1978; 34(4):200-7. PubMed ID: 146309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antigens specific for B-lymphoid cultured cell lines with human alloantisera.
    Mann DL; Abelson L; Harris S; Amos DB
    J Exp Med; 1975 Jul; 142(1):84-9. PubMed ID: 1080182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of xenoantiserum produced against B cell acute lymphoblastic leukemia cell line.
    Akagi T; Sonobe H; Miyoshi I; Yoshimoto S
    Acta Med Okayama; 1982 Oct; 36(5):325-30. PubMed ID: 6184955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal human sera cytotoxic to cells of human acute leukemia.
    Schacter B; Bias WB; Humphrey RL
    Tissue Antigens; 1976 Nov; 8(5):289-98. PubMed ID: 65021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity of anti-DRw sera evaluated by serologic studies on established B-lymphoid cell lines.
    Antonelli P; Kamoun M; Hansen JA; Dupont B
    Transplant Proc; 1978 Dec; 10(4):849-51. PubMed ID: 83719
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of cells expressing T and p28,33 (Ia-like) antigens in sections of human lymphoid tissue.
    Seymour GJ; Greaves MF; Janossy G
    Clin Exp Immunol; 1980 Jan; 39(1):66-75. PubMed ID: 6993067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screening program for anti-DR typing reagents.
    Vassalli P; Jeannet M; de Moerloose P; Chardonnens X
    Tissue Antigens; 1979 Jan; 13(1):77-80. PubMed ID: 311089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the stimulating capacity of human leukemia T-cell, null cell, and B-cell lines in mixed lymphoma culture.
    Tsubota T; Miyoshi I; Uno J; Hiraki S; Kimura I
    J Natl Cancer Inst; 1978 Apr; 60(4):793-5. PubMed ID: 147348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between HLA-DW and the b-lymphocyte specificities.
    Park MS; Terasaki PI; Saito S; Opelz G
    Scand J Immunol; 1977; 6(5):413-8. PubMed ID: 70058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.